Servier Egypt, a leading player in the pharmaceutical industry and part of the global Servier Group, proudly marked its ...
The WHO Executive Board will discuss global health priorities this week, including substandard and falsified medical products, with key implications for public pharmaceutical initiativesFor the next ...
Hosted on MSN4h
Eli Lilly (NYSE:LLY) Reports Q4 In Line With Expectations, Full-Year Outlook Slightly Exceeds ExpectationsGlobal pharmaceutical company Eli Lilly (NYSE:LLY) in Q4 CY2024, with sales up 44.7% year on year to $13.53 billion. The ...
In a statement sent to Pharmaceutical Executive, AMCP CEO Susan A. Cantrell, MHL, RPh, CAE, said, “Although President Trump’s ...
The United States' recent announcement to withdraw from the World Health Organization (WHO) has raised concerns across the global health community, particularly regarding the potential disruption of ...
China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients ...
Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on ...
US President Donald Trump's executive order imposing a 10 percent tariff on Chinese imports is likely to drive up the cost of ...
The Union Budget 2025 has waived import duty on 36 life-saving drugs and reduced it for six others. While this is expected to ...
The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback